A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction
Not Applicable
Completed
- Conditions
- Malignant Biliary Obstruction
- Registration Number
- NCT01869894
- Lead Sponsor
- Yonsei University
- Brief Summary
Our study is the prospective randomized study for efficacy of uncovered double bare metallic stent compared to uncovered single bare metallic stent in malignant biliary obstruction
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 73
Inclusion Criteria
- The patients who had malignant biliary obstruction
Exclusion Criteria
- The patients who had resectable biliary malignancy
- The patients who had hilar obstruction
- The patients who had duodenal obstruction
- The patients who had other malignancy which is not related to biliary obstruction
- The patients who had uncontrolled infection
- The patients who had poor performance (ECOG =3 or 4)
- The patients who were not acquired informed consent
- The patients who had technically difficult structure for ERCP
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Median patency duration Approximately 6 months later since the date of stent insertion Primary end point : A. Median patency duration
- Secondary Outcome Measures
Name Time Method 6-months patency rate Approximately 6 months later since the date of stent insertion Secondary end point : A. 6-months patency rate
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie stent patency differences between double and single bare metallic stents in malignant biliary obstruction?
How does the double bare metallic stent from S&G Biotech compare to Taewoong Medical's single stent in terms of clinical efficacy for malignant biliary obstruction?
Which biomarkers correlate with reduced stent occlusion or migration risk in patients receiving double vs. single bare metallic stents for biliary malignancies?
What are the adverse event profiles and management strategies for uncovered double vs. single bare metallic stents in malignant biliary obstruction trials?
How do uncovered double stents (S&G Biotech) compare to covered metallic stents or endoscopic therapies in treating malignant biliary obstruction?
Trial Locations
- Locations (1)
Severance Hospital, Yonsei University Health System
🇰🇷Seoul, Korea, Republic of
Severance Hospital, Yonsei University Health System🇰🇷Seoul, Korea, Republic of